BridgeBio Pharma, Inc. (BBIO)
Market Closed
17 Jul, 20:00
$
81. 38
+1.08
+1.345%
$
16.82B Market Cap
- P/E Ratio
- Div Yield
1.44M Volume
-3.85 Eps
$ 80.3
Previous Close 
Want to track BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BBIO Earnings Reports FAQ
What is the earnings per share (EPS) for BBIO?
The current EPS is -3.85.
What is the company's earnings growth rate?
BridgeBio Pharma, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
BridgeBio Pharma, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BridgeBio Pharma, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BBIO at this time, as BridgeBio Pharma, Inc has no recent EPS data to calculate it.
